Reducing the Data Footprint of Massive, Global Genomics Data
Geneformics Data Systems and WuXi NextCODE, the global contract genomics organization enabling precision medicine around the world, today announced a collaborative effort to integrate Geneformics technology into WuXi NexCODE’s workflows.
Geneformics leverages proprietary, optimized compression technologies to streamline the storage and sharing of genomics data in the cloud and on-premise. WuXi NextCODE’s database and analytics underpin the world’s leading population-scale precision medicine projects as well as pioneering diagnostics and wellness solutions on four continents. Together the companies intend to improve the efficiency of storing and transferring large-scale genomic data globally and increase the potential benefit of these datasets to patients.
The sequencing of a single whole genome generates more than 100 GB of raw data, making the storage, transfer and archiving of genomic data a huge challenge for the industry. Geneformics’ lossless compression has been demonstrated to reduce raw file size by up to 90 percent; combined with its storage and archiving technology, large genomic datasets can be compiled and queried on-site, remotely, or transferred online - with very significant efficiencies. Integrating Geneformics into the WuXi NextCODE platform thereby makes bigger datasets more accessible for precision medicine research, diagnosis and treatment.
“The combination of Geneformics’ technology and WuXi NextCODE’s workflows will enable a large range of customers to benefit from high-speed data transfer, efficient storage and archiving of genome sequence data,” said Rafael Feitelberg, Geneformics CEO. “As the platform for leading precision medicine efforts in the UK, Ireland, Qatar, Singapore, China and the US, WuXi NextCODE is an ideal technology partner. Together we will enable partners and customers to accelerate the discovery of data insights and reduce infrastructure costs.”
“Organizing, mining and sharing genomic big data is at the heart of our CGO model, and we expect Geneformics will help us to significantly reduce our data footprint to the benefit of our customers and to patients globally,” said Hannes Smarason, COO of WuXi NextCODE. “Geneformics does this through fast, lossless data compression and decompression, so customers can seamlessly access all their data, wherever it is sequenced or stored. Used in tandem with our sequencing, database and analytics, that gives CGO customers unrivalled power to solve rare disease cases, drive breakthrough discoveries, deliver carrier screening, tailor cancer treatment and support wellness.”
Have you ever been stressed out by the idea of doing math or statistics problems? You’re not alone. A new study has used a questionnaire and an analytical technique called "network science" to determine precisely what factors contribute to this kind of statistics anxiety among psychology majors.
Anxiety and depression are surprisingly common among young children. But it can be hard to detect these conditions, known as “internalizing disorders,” because the symptoms are so inward-facing that parents, teachers and doctors often fail to notice them. Now, researchers have developed a tool that could help screen children for internalizing disorders to catch them early enough to be treated.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019